Centiva Capital, LP Morpho Sys Ag Transaction History

Centiva Capital, LP

  • $3.13 Billion
  • Q1 2025

A detailed history of Centiva Capital, LP transactions in Morpho Sys Ag stock. As of the latest transaction made, Centiva Capital, LP holds 10,000 shares of MOR stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$0
% of portfolio
0.0%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

Others Institutions Holding MOR

# of Institutions
4
Shares Held
1.66M
Call Options Held
0
Put Options Held
14.7K
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email